View : 13 Download: 0

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

Title
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
Authors
Song H.S.Do Y.R.Chang H.M.Ryu M.H.Lee K.H.Kim Y.H.Hong D.S.Cho J.Y.Lee K.E.Kim S.Y.
Ewha Authors
이경은
SCOPUS Author ID
이경은scopus
Issue Date
2008
Journal Title
Cancer Chemotherapy and Pharmacology
ISSN
0344-5704JCR Link
Citation
vol. 62, no. 5, pp. 763 - 768
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
Purpose: This open-label, multicenter phase II study was conducted to investigate the efficacy and safety of capecitabine plus gemcitabine combination chemotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer. Patients and methods: We enrolled 63 patients who received capecitabine 830 mg/m2 orally twice daily on days 1-21 plus gemcitabine 1000 mg/m2 as a 30-min infusion on days 1, 8 and 15 every 4 weeks for up to six cycles. Results: A total of 14 patients had partial responses giving an overall response rate of 22% (95% confidence interval [CI] 13-34%) in the intent-to-treat population. The median time to progression and overall survival were 3.9 months (95% CI 3.5-5.7) and 7.5 months (95% CI 5.0-10.0), respectively, and 1-year survival rate was 27.1% in the intent-to-treat population. Capecitabine plus gemcitabine was well tolerated. Grade 3 hematological adverse events were neutropenia (21%) and thrombocytopenia (2%); the only grade 4 hematological events were anemia (2%) and neutropenia (6%). Non-hematological adverse events were mainly gastrointestinal events and hand-foot syndrome, which affected 16% of patients. Grade 3/4 non-hematological events were infrequent. Conclusion: The combination of capecitabine plus gemcitabine appears to be active and well tolerated as first-line treatment in patients with advanced/metastatic pancreatic cancer. © 2007 Springer-Verlag.
DOI
10.1007/s00280-007-0661-y
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE